You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epoetin biosimilar

Showing 1 - 25 of 485
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Anaemia Trial in Bangkok (EPIAO®, EPREX®)

Terminated
  • Renal Anaemia
  • Bangkok, Thailand
  • +7 more
Oct 19, 2020

Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

Not yet recruiting
  • Multiple Myeloma
  • +3 more
  • (no location specified)
Oct 30, 2023

Natural Blood and Blood Product Toxicity Trial in Dhaka (Erythropoietin alpha)

Completed
  • Natural Blood and Blood Product Toxicity
  • Erythropoietin alpha
  • Dhaka, Bangladesh
  • +1 more
Oct 18, 2022

Renal Anemia Trial in Russian Federation, Thailand (EPREX®, EPIAO®)

Recruiting
  • Renal Anemia
  • Volzhskiy, Volgogradskaya Region, Russian Federation
  • +18 more
Oct 19, 2020

Hidradenitis Suppurativa Trial in Lahore (Infliximab biosimilar)

Active, not recruiting
  • Hidradenitis Suppurativa
  • Infliximab biosimilar
  • Lahore, Punjab, Pakistan
    Services Institute of Medical Sciences
Dec 22, 2022

Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic Trial in Boston (Sacituzumab Govitecan,

Not yet recruiting
  • Her 2 Positive Breast Cancer
  • +2 more
  • Sacituzumab Govitecan
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 25, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

Recruiting
  • Pharmacokinetics
  • Pharmacodynamics
  • Chula Vista, California
    Amphastar Study Site
Sep 13, 2022

Psoriasis Trial in Worldwide (Stelara, AVT04)

Completed
  • Psoriasis
  • Tallinn, Estonia
  • +29 more
Feb 1, 2023

Healthy Adult Subjects Trial in Christchurch (AVT05, Simponi)

Recruiting
  • Healthy Adult Subjects
  • AVT05
  • Simponi
  • Christchurch, New Zealand
    New Zealand Clinical Research
Jan 13, 2023

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou (Bevacizumab Biosimilar QL 1101)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Bevacizumab Biosimilar QL 1101
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 20, 2023

Breast Cancer Trial in Saint Petersburg (BCD-178, Perjeta)

Active, not recruiting
  • Breast Cancer
  • Saint Petersburg, Russian Federation
  • +1 more
Feb 13, 2023

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

Infertility Trial in Xi'an (Biosimilar cetrorelix acetate, Reference cetrorelix acetate)

Not yet recruiting
  • Infertility
  • Biosimilar cetrorelix acetate
  • Reference cetrorelix acetate
  • Xi'an, None Selected, China
    He Cai
Sep 7, 2023

Anemia, Intensive Care Trial (Erythropoietin, Placebo)

Active, not recruiting
  • Anemia
  • Intensive Care
  • Cholet, France
  • +1 more
Oct 5, 2022

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared

Recruiting
  • ANCA-associated Vasculitis
  • +2 more
    • Calgary, Alberta, Canada
    • +8 more
    Jan 27, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)

    Recruiting
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 4, 2023

    Postmenopausal Osteoporosis Trial in Beijing (CMAB807 Injection, Prolia®)

    Recruiting
    • Postmenopausal Osteoporosis
    • Beijing, Beijing, China
      Peking Union Medical College Hosptial
    Jun 14, 2022

    Rheumatoid Arthritis (RA) Trial in Worldwide (NI-071, Infliximab)

    Completed
    Has Results
    • Rheumatoid Arthritis
    • Little Rock, Arkansas
    • +133 more
    Jan 26, 2023

    Erythropoiesis Stimulating Agents for Anemia Management in

    Completed
    • Anemia of Chronic Kidney Disease
    • +2 more
      • Giza, Egypt
        the Memorial Souad Kafafi University Hospital
      Jan 24, 2023

      MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Luspatercept
      • Epoetin Alfa
      • Concord, California
      • +100 more
      Jul 20, 2023

      Long-term Treatment With YISAIPU for Fujian RA Patients

      Recruiting
      • Rheumatoid Arthritis
      • YISAIPU® ( An etanercept biosimilar)
      • csDMARDs
      • Xiamen, Fujian, China
        The First Affiliated Hospital of Xiamen University
      Jun 15, 2022

      ST Elevation Myocardial Infarction Trial in Russian Federation (GNR-060, Metalyse)

      Recruiting
      • ST Elevation Myocardial Infarction
      • GNR-060
      • Metalyse
      • Barnaul, Altai Territory, Russian Federation
      • +10 more
      Oct 31, 2022

      Breast Cancer Trial in Shanghai (sintilimab, bevacizumab biosimilar, pegylated liposomal doxorubicin)

      Recruiting
      • Breast Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      May 22, 2022